MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BILEZIKIAN, J. P.
Right arrow Articles by AURBACH, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BILEZIKIAN, J. P.
Right arrow Articles by AURBACH, G. D.

Molecular Pharmacology, Vol 13, 775-785, Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics

Identification and Persistence of Beta Adrenergic Receptors during Maturation of the Rat Reticulocyte

JOHN P. BILEZIKIAN 1, ALLEN M. SPIEGEL 1, EDWARD M. BROWN 1, and GERALD D. AURBACH 1

1 Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032, and Section on Mineral Metabolism, Metabolic Diseases Branch, National Institute of Arthritis, Metabolic, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014

Rat erythrocytes and reticulocytes have been studied in relation to their responsiveness to beta adrenergic catecholamines. The characteristics of beta adrenergic receptors after induction of a maximal reticulocyte response with phenylhydrazine hydrochloride and after differentiation to morphologically mature erythrocytes were compared and correlated with concomitant changes in catecholamine-sensitive adenylate cyclase activity. Membranes from a population of 90% reticulocytes contain 25 times more adenylate cyclase activity than membranes from erythrocytes (5% reticulocytes). The potencies of a series of agonists and antagonists define this activity as beta adrenergic. Adenylate cyclase activity varies directly with the reticulocyte percentage. Iodohydroxybenzylpindolol, a potent beta adrenergic inhibitor that has been used successfully to detect beta receptors, binds to sites in both control and reticulocyte membranes with high affinity (KD = 0.2 nM), low capacity, and stereospecificity. Adrenergic compounds that stimulate or inhibit adenylate cyclase bind to the beta receptor over a similar concentration range. Control erythrocytes from untreated rats and erythrocytes formed after reticulocytes have been allowed to mature contain approximately half the receptors of reticulocytes. Characteristics of the beta receptor from reticulocytes and mature erythrocytes are indistinguishable. Catecholamine-sensitive adenylate cyclase is rapidly lost as the reticulocyte matures, but significant binding activity persists. These observations suggest that the beta receptor may become uncoupled from the catalytic unit of adenylate cyclase during differentiation. The results are also compatible with the hypothesis that beta adrenergic catecholamines play a role in erythroid differentiation.

Note:
ACKNOWLEDGMENTS The expert technical assistance of Mr. Donald Gammon and Mr. Charles Woodard is appreciated.

Submitted on November 26, 1976
Accepted on April 11, 1977




This article has been cited by other articles:


Home page
ScienceHome page
W. Strittmatter, F Hirata, and J Axelrod
Phospholipid methylation unmasks cryptic beta-adrenergic receptors in rat reticulocytes
Science, June 15, 1979; 204(4398): 1205 - 1207.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics